Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

It was a dose of qualified good news ... the government is supposed to save from drug price negotiations is very close to the amount Medicare has already lost thanks to Big Pharma’s abuse ...

Attacking Big Pharma, whose public opinion is lower than any other industry, and lower than the public’s opinion of the government, is right out of the populist playbook. But it is also good ...

President Trump took aim at Big Pharma on Monday by signing an executive ... progress” within six months would trigger further government action, including the potential use of tariffs.